KEA to Take Over D Pharma Counselling from 2025-26 to Curb Vacant Govt Seats
- byDoctor News Daily Team
- 14 September, 2025
- 0 Comments
- 0 Mins

Bengaluru: The Karnataka Examinations Authority (KEA) will conduct counselling for Diploma in Pharmacy (D Pharma) admissions, from the academic year 2025-26, both for government and private quota seats, replacing the existing manual process. The move follows concerns that between 2022-23 and 2024-25, a majority of government quota seats were left vacant even as private quota seats were being filled. Out of nearly 4,000 available seats, only around 800 were allotted during this period, highlighting inefficiencies in the manual counselling system handled by the Board of Examination Authority Pharmacy. Under the earlier procedure, counselling was based on II PU marks but carried out manually, often leading to confusion among students and delays in allotments. Officials admitted that the system not only slowed down the process but also resulted in significant wastage of government seats year after year. In its order, the state government highlighted that KEA already manages counselling for a wide range of courses, including diploma, undergraduate, postgraduate and D-Pharma programmes in other streams. “Since KEA conducts counselling for all other diploma, degree, postgraduate and D-Pharma courses, conducting the same for D-Pharma course will ensure a standardised system. As KEA also conducts computerised robotic counselling, it reduces manual errors, confusion and malpractice in the process,” the order read. Times of Indiareports that KEA’s centralised, computerised counselling is expected to bring greater transparency, streamline admissions and ensure optimal utilisation of the state’s D-Pharma capacity. Officials believe the shift will also help restore student confidence in the process by making seat allocation quicker, clearer and less prone to manipulation. Also Read: D Pharma Student's Unlicensed Store Busted in Haryana, ACB Arrests Drug Official During Raid
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
TN Nursing admissions 2025: Check out round 2 sche...
- 18 September, 2025
AIIMS Rishikesh notifies reporting guidelines for...
- 18 September, 2025
'Stipend cannot be given to FMG Interns'- says Guj...
- 18 September, 2025
MCC NEET 2025 Round 2 Counselling Final Results OU...
- 18 September, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!